GAMMA Investing’s MediWound MDWD Stock Holding History

GAMMA Investing’s Portfolio MDWD Stock Details MDWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.49K	Buy	399 +78	+24%	+$1.08K	﹤0.01%	3607
2026 Q2	$4.72K	Buy	321 +47	+17%	+$746	﹤0.01%	3493
2026 Q1	$4.41K	Buy	274 +217	+381%	+$3.77K	﹤0.01%	3404
2025 Q4	$1.05K	Sell	57 -7	-11%	-$128	﹤0.01%	3777
2025 Q3	$1.15K	Sell	64 -19	-23%	-$350	﹤0.01%	3584
2025 Q2	$1.61K	Sell	83 -34	-29%	-$641	﹤0.01%	3443
2025 Q1	$1.82K	Buy	117 +4	+4%	+$72	﹤0.01%	3435
2024 Q4	$2.01K	Buy	113 +109	+2,725%	+$1.88K	﹤0.01%	3220
2024 Q3	$72	Buy	+4	New	+$73	﹤0.01%	3562

Other funds holding MDWD

SBCM

Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

MWP

Meriwether Wealth & Planning Minden, Louisiana $222M AUM 15.77% 1-Year Est. Return

GAMMA Investing's MDWD Position: Q3 2026 in Review

GAMMA Investing increased its MediWound (MDWD) stake by 24% in Q3 2026, buying an estimated $1.08K and bringing the position to 399 shares worth $5.49K. The position accounts for ﹤0.01% of the portfolio, ranked #3607.

GAMMA Investing first reported a position in MDWD in Q3 2024 and has held it in 9 quarters since. 6 funds tracked by Wall St. Rank hold MDWD as of Q3 2026.

GAMMA Investing held 399 shares of MediWound worth $5.49K as of Q3 2026.
GAMMA Investing bought 78 MediWound shares in Q3 2026, an estimated $1.08K.
MediWound made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3607 holding.
GAMMA Investing first reported a position in MediWound in Q3 2024 and has held it in 9 quarters since.
6 funds tracked by Wall St. Rank held MediWound as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.